These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 31806428)
1. Pro-inflammatory cytokines are associated with podocyte damage and proximal tubular dysfunction in the early stage of diabetic kidney disease in type 2 diabetes mellitus patients. Milas O; Gadalean F; Vlad A; Dumitrascu V; Velciov S; Gluhovschi C; Bob F; Popescu R; Ursoniu S; Jianu DC; Matusz P; Pusztai AM; Secara A; Simulescu A; Stefan M; Patruica M; Petrica F; Vlad D; Petrica L J Diabetes Complications; 2020 Feb; 34(2):107479. PubMed ID: 31806428 [TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNAs may impact podocytes and proximal tubule function through modulating miRNAs expression in Early Diabetic Kidney Disease of Type 2 Diabetes Mellitus patients. Petrica L; Hogea E; Gadalean F; Vlad A; Vlad M; Dumitrascu V; Velciov S; Gluhovschi C; Bob F; Ursoniu S; Jianu DC; Matusz P; Pusztai AM; Motoc A; Cretu OM; Radu D; Milas O; Golea-Secara A; Simulescu A; Mogos-Stefan M; Patruica M; Balint L; Ienciu S; Vlad D; Popescu R Int J Med Sci; 2021; 18(10):2093-2101. PubMed ID: 33859515 [No Abstract] [Full Text] [Related]
3. Deregulated profiles of urinary microRNAs may explain podocyte injury and proximal tubule dysfunction in normoalbuminuric patients with type 2 diabetes mellitus. Milas O; Gadalean F; Vlad A; Dumitrascu V; Gluhovschi C; Gluhovschi G; Velciov S; Popescu R; Bob F; Matusz P; Pusztai AM; Cretu OM; Secara A; Simulescu A; Ursoniu S; Vlad D; Petrica L J Investig Med; 2018 Apr; 66(4):747-754. PubMed ID: 29279420 [TBL] [Abstract][Full Text] [Related]
4. Mitochondrial DNA Changes in Blood and Urine Display a Specific Signature in Relation to Inflammation in Normoalbuminuric Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients. Petrica L; Vlad A; Gadalean F; Muntean DM; Vlad D; Dumitrascu V; Bob F; Milas O; Suteanu-Simulescu A; Glavan M; Jianu DC; Ursoniu S; Balint L; Mogos-Stefan M; Ienciu S; Cretu OM; Popescu R Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372951 [TBL] [Abstract][Full Text] [Related]
5. Podocyturia parallels proximal tubule dysfunction in type 2 diabetes mellitus patients independently of albuminuria and renal function decline: A cross-sectional study. Petrica L; Vlad M; Vlad A; Gluhovschi G; Gadalean F; Dumitrascu V; Popescu R; Gluhovschi C; Matusz P; Velciov S; Bob F; Ursoniu S; Vlad D J Diabetes Complications; 2017 Sep; 31(9):1444-1450. PubMed ID: 28161386 [TBL] [Abstract][Full Text] [Related]
6. MiRNA Expression is Associated with Clinical Variables Related to Vascular Remodeling in the Kidney and the Brain in Type 2 Diabetes Mellitus Patients. Petrica L; Pusztai AM; Vlad M; Vlad A; Gadalean F; Dumitrascu V; Vlad D; Velciov S; Gluhovschi C; Bob F; Ursoniu S; Petrica M; Matusz P; Cretu O; Radu D; Milas O; Secara A; Simulescu A; Popescu R; Jianu DC Endocr Res; 2020; 45(2):119-130. PubMed ID: 31724439 [No Abstract] [Full Text] [Related]
7. Increased Urinary Excretion of Podocyte Markers in Normoalbuminuric Patients with Diabetes. Lioudaki E; Stylianou KG; Petrakis I; Kokologiannakis G; Passam A; Mikhailidis DP; Daphnis EK; Ganotakis ES Nephron; 2015; 131(1):34-42. PubMed ID: 26340089 [TBL] [Abstract][Full Text] [Related]
8. Therapy with atorvastatin versus rosuvastatin reduces urinary podocytes, podocyte-associated molecules, and proximal tubule dysfunction biomarkers in patients with type 2 diabetes mellitus: a pilot study. Vlad A; Vlad M; Petrica L; Ursoniu S; Gadalean F; Popescu R; Vlad D; Dumitrascu V; Gluhovschi G; Gluhovschi C; Velciov S; Bob F; Matusz P; Secara A; Simulescu A; Jianu DC Ren Fail; 2017 Nov; 39(1):112-119. PubMed ID: 27841047 [TBL] [Abstract][Full Text] [Related]
9. Proximal tubule dysfunction is associated with podocyte damage biomarkers nephrin and vascular endothelial growth factor in type 2 diabetes mellitus patients: a cross-sectional study. Petrica L; Vlad A; Gluhovschi G; Gadalean F; Dumitrascu V; Gluhovschi C; Velciov S; Bob F; Vlad D; Popescu R; Milas O; Ursoniu S PLoS One; 2014; 9(11):e112538. PubMed ID: 25397960 [TBL] [Abstract][Full Text] [Related]
10. Mitochondrial DNA and Inflammation Are Associated with Cerebral Vessel Remodeling and Early Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus. Petrica L; Gadalean F; Muntean DM; Jianu DC; Vlad D; Dumitrascu V; Bob F; Milas O; Suteanu-Simulescu A; Glavan M; Ursoniu S; Balint L; Mogos-Stefan M; Ienciu S; Cretu OM; Popescu R; Gluhovschi C; Iancu L; Vlad A Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672515 [TBL] [Abstract][Full Text] [Related]
11. Urinary podocyte-associated mRNA levels correlate with proximal tubule dysfunction in early diabetic nephropathy of type 2 diabetes mellitus. Petrica L; Ursoniu S; Gadalean F; Vlad A; Gluhovschi G; Dumitrascu V; Vlad D; Gluhovschi C; Velciov S; Bob F; Matusz P; Milas O; Secara A; Simulescu A; Popescu R Diabetol Metab Syndr; 2017; 9():31. PubMed ID: 28484521 [TBL] [Abstract][Full Text] [Related]
12. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase. Vaidya VS; Niewczas MA; Ficociello LH; Johnson AC; Collings FB; Warram JH; Krolewski AS; Bonventre JV Kidney Int; 2011 Feb; 79(4):464-70. PubMed ID: 20980978 [TBL] [Abstract][Full Text] [Related]
13. Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy. Fujita H; Morii T; Koshimura J; Ishikawa M; Kato M; Miura T; Sasaki H; Narita T; Ito S; Kakei M Endocr J; 2006 Dec; 53(6):745-52. PubMed ID: 16966829 [TBL] [Abstract][Full Text] [Related]
14. Urine synaptopodin excretion is an important marker of glomerular disease progression. Kwon SK; Kim SJ; Kim HY Korean J Intern Med; 2016 Sep; 31(5):938-43. PubMed ID: 27604800 [TBL] [Abstract][Full Text] [Related]
15. Intra-renal and urinary mRNA expression of podocyte-associated molecules for the estimation of glomerular podocyte loss. Wang G; Lai FM; Lai KB; Chow KM; Kwan BC; Li KT; Szeto CC Ren Fail; 2010 Jan; 32(3):372-9. PubMed ID: 20370455 [TBL] [Abstract][Full Text] [Related]
16. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients. Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044 [TBL] [Abstract][Full Text] [Related]
17. Urinary podocyte mRNAs precede microalbuminuria as a progression risk marker in human type 2 diabetic nephropathy. Fukuda A; Minakawa A; Kikuchi M; Sato Y; Nagatomo M; Nakamura S; Mizoguchi T; Fukunaga N; Shibata H; Naik AS; Wiggins RC; Fujimoto S Sci Rep; 2020 Oct; 10(1):18209. PubMed ID: 33097787 [TBL] [Abstract][Full Text] [Related]
18. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes. de Carvalho JA; Tatsch E; Hausen BS; Bollick YS; Moretto MB; Duarte T; Duarte MM; Londero SW; Premaor MO; Comim FV; Delanghe JR; Moresco RN Clin Biochem; 2016 Feb; 49(3):232-6. PubMed ID: 26519090 [TBL] [Abstract][Full Text] [Related]